CD274 and lung adenocarcinoma: Previous studies have demonstrated that lung adenocarcinoma patients showed a 49.6 to 62.7% negative PD-L1 expression, 25.2 to 34.3% weak PD-L1 expressions, and 11.8 to 17.6% strong PD-L1 expressions20,21,28.